Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-(3-Carboxypropanoyl)-L-phenylalanyl-3-carboxy-O-(carboxymethyl)-N-pentyl-L-tyrosinamide is a synthetic small molecule with the molecular formula C30H37N3O10 and a molecular weight of approximately 599.6 g/mol[1][2][3]. It is classified as an experimental compound and listed in chemical databases such as PubChem (CID 445785), DrugBank (DB04525), and ChEMBL (CHEMBL175198)[1][2]. The compound belongs to the class of dipeptides, containing two amino acids linked by a peptide bond[1][2]. There are no approved therapeutic indications, clinical trials, or known mechanisms of action reported for this molecule. Its pharmacological activity, mechanism of action, developer information, and potential clinical applications remain uncharacterized in public scientific resources[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-(3-carboxypropanoyl)-L-phenylalanyl-3-carboxy-O-(carboxymethyl)-N-pentyl-L-tyrosinamide.